Cargando…

Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders

Backgrounds and Purpose. Philadelphia chromosome-negative myeloproliferative disorders (Ph-negative MPD) are a rare group of hematological diseases, including three distinct pathologies: essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF). They most often manifest...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuznetsova, Polina I., Raskurazhev, Anton A., Konovalov, Rodion N., Krotenkova, Marina V., Chechetkin, Andrey O., Lagoda, Olga V., Melikhyan, Anait L., Tanashyan, Marine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745571/
https://www.ncbi.nlm.nih.gov/pubmed/35011753
http://dx.doi.org/10.3390/jcm11010013
_version_ 1784630377523970048
author Kuznetsova, Polina I.
Raskurazhev, Anton A.
Konovalov, Rodion N.
Krotenkova, Marina V.
Chechetkin, Andrey O.
Lagoda, Olga V.
Melikhyan, Anait L.
Tanashyan, Marine M.
author_facet Kuznetsova, Polina I.
Raskurazhev, Anton A.
Konovalov, Rodion N.
Krotenkova, Marina V.
Chechetkin, Andrey O.
Lagoda, Olga V.
Melikhyan, Anait L.
Tanashyan, Marine M.
author_sort Kuznetsova, Polina I.
collection PubMed
description Backgrounds and Purpose. Philadelphia chromosome-negative myeloproliferative disorders (Ph-negative MPD) are a rare group of hematological diseases, including three distinct pathologies: essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF). They most often manifest with thrombotic complications, including cerebrovascular events. Covert brain infarcts (CBIs) are defin ed as predominantly small ischemic cerebral lesions that are detected using magnetic resonance imaging (MRI) in the absence of clinical stroke events. The relationship between MPD and CBIs remains unclear. Methods. Included in the study were 103 patients with the diagnosis of Ph-MPD (according to WHO 2016 criteria) (median age—47 (35; 54) years; 67% female). In total, 38 patients had ET, 42 had PV, and 23 had PMF. They underwent clinical examination, routine laboratory analyses (complete blood count), brain MRI, ultrasound carotid artery, flow-mediated dilatation (as a measure of endothelial dysfunction—FMD). Results. Overall, 23 patients experienced an ischemic stroke (as per MRI and/or clinical history), of which 16 (15.5%) could be classified as CBIs. The rate of CBIs per MPD subtype was statistically non-significant between groups (p = 0.35): ET–13.2%, PV–21.4%, and PMF–8.7%. The major vascular risk factors, including arterial hypertension, carotid atherosclerosis, and prior venous thrombosis, were not associated with CBIs (p > 0.05). Age was significantly higher in patients with CBIs compared to patients without MRI ischemic lesions: 50 (43; 57) years vs. 36 (29; 48) (p = 0.002). The frequency of headaches was comparable between the two groups. CBIs were associated with endothelial dysfunction (OR - 0.71 (95% CI: 0.49–0.90; p = 0.02)) and higher hemoglobin levels (OR—1.21 (95% CI: 1.06–1.55); p =0.03). Conclusions. CBIs are common in patients with Ph-negative MPD. Arterial hypertension and carotid atherosclerosis were not associated with CBIs in this group of patients. The most significant factors in the development of CBIs were endothelial dysfunction (as measured by FMD) and high hemoglobin levels. Patients with Ph-negative MPD and CBIs were older and had more prevalent endothelial dysfunction.
format Online
Article
Text
id pubmed-8745571
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87455712022-01-11 Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders Kuznetsova, Polina I. Raskurazhev, Anton A. Konovalov, Rodion N. Krotenkova, Marina V. Chechetkin, Andrey O. Lagoda, Olga V. Melikhyan, Anait L. Tanashyan, Marine M. J Clin Med Article Backgrounds and Purpose. Philadelphia chromosome-negative myeloproliferative disorders (Ph-negative MPD) are a rare group of hematological diseases, including three distinct pathologies: essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF). They most often manifest with thrombotic complications, including cerebrovascular events. Covert brain infarcts (CBIs) are defin ed as predominantly small ischemic cerebral lesions that are detected using magnetic resonance imaging (MRI) in the absence of clinical stroke events. The relationship between MPD and CBIs remains unclear. Methods. Included in the study were 103 patients with the diagnosis of Ph-MPD (according to WHO 2016 criteria) (median age—47 (35; 54) years; 67% female). In total, 38 patients had ET, 42 had PV, and 23 had PMF. They underwent clinical examination, routine laboratory analyses (complete blood count), brain MRI, ultrasound carotid artery, flow-mediated dilatation (as a measure of endothelial dysfunction—FMD). Results. Overall, 23 patients experienced an ischemic stroke (as per MRI and/or clinical history), of which 16 (15.5%) could be classified as CBIs. The rate of CBIs per MPD subtype was statistically non-significant between groups (p = 0.35): ET–13.2%, PV–21.4%, and PMF–8.7%. The major vascular risk factors, including arterial hypertension, carotid atherosclerosis, and prior venous thrombosis, were not associated with CBIs (p > 0.05). Age was significantly higher in patients with CBIs compared to patients without MRI ischemic lesions: 50 (43; 57) years vs. 36 (29; 48) (p = 0.002). The frequency of headaches was comparable between the two groups. CBIs were associated with endothelial dysfunction (OR - 0.71 (95% CI: 0.49–0.90; p = 0.02)) and higher hemoglobin levels (OR—1.21 (95% CI: 1.06–1.55); p =0.03). Conclusions. CBIs are common in patients with Ph-negative MPD. Arterial hypertension and carotid atherosclerosis were not associated with CBIs in this group of patients. The most significant factors in the development of CBIs were endothelial dysfunction (as measured by FMD) and high hemoglobin levels. Patients with Ph-negative MPD and CBIs were older and had more prevalent endothelial dysfunction. MDPI 2021-12-21 /pmc/articles/PMC8745571/ /pubmed/35011753 http://dx.doi.org/10.3390/jcm11010013 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kuznetsova, Polina I.
Raskurazhev, Anton A.
Konovalov, Rodion N.
Krotenkova, Marina V.
Chechetkin, Andrey O.
Lagoda, Olga V.
Melikhyan, Anait L.
Tanashyan, Marine M.
Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders
title Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders
title_full Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders
title_fullStr Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders
title_full_unstemmed Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders
title_short Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders
title_sort covert brain infarcts in patients with philadelphia chromosome-negative myeloproliferative disorders
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745571/
https://www.ncbi.nlm.nih.gov/pubmed/35011753
http://dx.doi.org/10.3390/jcm11010013
work_keys_str_mv AT kuznetsovapolinai covertbraininfarctsinpatientswithphiladelphiachromosomenegativemyeloproliferativedisorders
AT raskurazhevantona covertbraininfarctsinpatientswithphiladelphiachromosomenegativemyeloproliferativedisorders
AT konovalovrodionn covertbraininfarctsinpatientswithphiladelphiachromosomenegativemyeloproliferativedisorders
AT krotenkovamarinav covertbraininfarctsinpatientswithphiladelphiachromosomenegativemyeloproliferativedisorders
AT chechetkinandreyo covertbraininfarctsinpatientswithphiladelphiachromosomenegativemyeloproliferativedisorders
AT lagodaolgav covertbraininfarctsinpatientswithphiladelphiachromosomenegativemyeloproliferativedisorders
AT melikhyananaitl covertbraininfarctsinpatientswithphiladelphiachromosomenegativemyeloproliferativedisorders
AT tanashyanmarinem covertbraininfarctsinpatientswithphiladelphiachromosomenegativemyeloproliferativedisorders